The 'Dispatched' Week in Review' Podcast - 15 May

This is a preview of subscriber content

Subscribe now to continue reading.

There are enough measures and signals in this week's Budget to suggest medicines, vaccines and other technologies were discussed extensively in the process leading up to Tuesday's announcement. It might also help explain Health Minister Mark Butler's annoyance at one organisation's response. A Government response to a parliamentary inquiry triggered another odd response from stakeholder groups. …

Subscribe now to continue reading.

The 'Dispatched' Week in Review' Podcast - 15 May

This is a preview of subscriber content

Latest Video

Most Read

Officials talk down the prospect of MFN impact on the PBS

An exchange that reveals the truth of a review that has now become a lot like 'Weekend at Bernie's'

Invitation confusion clouds Delphi studies and captures medical device sector

Officials confirm shift in Budget management of underspends

Officials cite company consultation, system changes, and spending approvals to justify delay

New Stories

Opthea returns to ASX and works to restart eye therapy candidate

A clear disconnect between the public and private on 'Most Favored Nation' pricing

New blueprint charts a potential policy path forward on biosimilars

Officials cite company consultation, system changes, and spending approvals to justify delay

Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science

Study confirms pharmacist led care expands timely access to urinary tract infection treatment and contraception

Officials talk down the prospect of MFN impact on the PBS

Sign In

The 'Dispatched' Week in Review' Podcast - 15 May

This is a preview of subscriber content

Latest Video

Most Read

Officials talk down the prospect of MFN impact on the PBS

An exchange that reveals the truth of a review that has now become a lot like 'Weekend at Bernie's'

Invitation confusion clouds Delphi studies and captures medical device sector

Officials confirm shift in Budget management of underspends

Officials cite company consultation, system changes, and spending approvals to justify delay

Follow Us

New Stories

Opthea returns to ASX and works to restart eye therapy candidate

A clear disconnect between the public and private on 'Most Favored Nation' pricing

New blueprint charts a potential policy path forward on biosimilars

Officials cite company consultation, system changes, and spending approvals to justify delay

Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science

Study confirms pharmacist led care expands timely access to urinary tract infection treatment and contraception

Officials talk down the prospect of MFN impact on the PBS